Soda, Rosario, et al. “Systemic Therapy of Primary Cutaneous B-Cell Lymphoma, Marginal Zone Type, With Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody”. Acta Dermato-Venereologica, vol. 81, no. 3, May 2001, pp. 207-8, doi:10.1080/000155501750376339.